Skip to main content
News2023-issue-2MIMOS Snippets

Advancing Medical Technology and Data Collection with REVA

A health screening was held for two days, from 10 to 11 May 2023, for MIMOSians using MIMOS REVA, Reagentless Vital Sign Analyser for non-intrusive blood testing and vital signs screening.

REVA Health Screening

MIMOSians voluntarily participated in the clinical data collection aimed to test the new improved and upgraded REVA RP2 device. The new features were added to achieve a higher level of accuracy with the REVA algorithm, achieving a higher standard of compliance with the non-intrusive method.

The test was successful, thanks to MIMOSians volunteers and Lablink Medical Laboratory Malaysia for collaborating with us.